KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Long-Term Investments (2016 - 2026)

Gilead Sciences filings provide 16 years of Long-Term Investments readings, the most recent being $3.0 billion for Q4 2025.

  • On a quarterly basis, Long-Term Investments changed N/A to $3.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $3.0 billion, a N/A change, with the full-year FY2025 number at $3.0 billion, changed N/A from a year prior.
  • Long-Term Investments hit $3.0 billion in Q4 2025 for Gilead Sciences, up from $2.0 billion in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $3.0 billion in Q4 2025 to a low of $579.0 million in Q1 2021.
  • Median Long-Term Investments over the past 4 years was $1.3 billion (2021), compared with a mean of $1.4 billion.
  • The widest YoY moves for Long-Term Investments: up 160.76% in 2021, down 83.59% in 2021.
  • Gilead Sciences' Long-Term Investments stood at $1.3 billion in 2021, then decreased by 4.89% to $1.2 billion in 2022, then decreased by 6.59% to $1.2 billion in 2023, then soared by 155.72% to $3.0 billion in 2025.
  • The last three reported values for Long-Term Investments were $3.0 billion (Q4 2025), $2.0 billion (Q3 2025), and $1.9 billion (Q2 2025) per Business Quant data.